This document is an excerpt from the EUR-Lex website
Document 02013R0609-20230321
Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (Text with EEA relevance)Text with EEA relevance
Consolidated text: Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (Text with EEA relevance)Text with EEA relevance
Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (Text with EEA relevance)Text with EEA relevance
02013R0609 — EN — 21.03.2023 — 003.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
REGULATION (EU) No 609/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (OJ L 181 29.6.2013, p. 35) |
Amended by:
|
|
Official Journal |
||
No |
page |
date |
||
COMMISSION DELEGATED REGULATION (EU) 2017/1091 of 10 April 2017 |
L 158 |
5 |
21.6.2017 |
|
COMMISSION DELEGATED REGULATION (EU) 2021/571 of 20 January 2021 |
L 120 |
1 |
8.4.2021 |
|
COMMISSION DELEGATED REGULATION (EU) 2023/439 of 16 December 2022 |
L 64 |
1 |
1.3.2023 |
REGULATION (EU) No 609/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 12 June 2013
on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009
(Text with EEA relevance)
CHAPTER I
GENERAL PROVISIONS
Article 1
Subject matter
This Regulation establishes compositional and information requirements for the following categories of food:
infant formula and follow-on formula;
processed cereal-based food and baby food;
food for special medical purposes;
total diet replacement for weight control.
Article 2
Definitions
For the purposes of this Regulation, the following definitions shall apply:
the definitions of ‘food’, ‘food business operator’, ‘retail’ and ‘placing on the market’ set out respectively in Article 2 and points (3), (7) and (8) of Article 3 of Regulation (EC) No 178/2002;
the definitions of ‘prepacked food’, ‘labelling’ and ‘engineered nanomaterial’ set out respectively in points (e), (j) and (t) of Article 2(2) of Regulation (EU) No 1169/2011;
the definitions of ‘nutrition claim’ and ‘health claim’ set out respectively in points (4) and (5) of Article 2(2) of Regulation (EC) No 1924/2006.
The following definitions shall also apply:
‘infant’ means a child under the age of 12 months;
‘young child’ means a child aged between one and three years;
‘infant formula’ means food intended for use by infants during the first months of life and satisfying by itself the nutritional requirements of such infants until the introduction of appropriate complementary feeding;
‘follow-on formula’ means food intended for use by infants when appropriate complementary feeding is introduced and which constitutes the principal liquid element in a progressively diversified diet of such infants;
‘processed cereal-based food’ means food:
intended to fulfil the particular requirements of infants in good health while they are being weaned, and of young children in good health as a supplement to their diet and/or for their progressive adaptation, to ordinary food; and
pertaining to one of the following categories:
‘baby food’ means food intended to fulfil the particular requirements of infants in good health while they are being weaned, and of young children in good health as a supplement to their diet and/or for their progressive adaptation to ordinary food, excluding:
processed cereal-based food; and
milk-based drinks and similar products intended for young children;
‘food for special medical purposes’ means food specially processed or formulated and intended for the dietary management of patients, including infants, to be used under medical supervision; it is intended for the exclusive or partial feeding of patients with a limited, impaired or disturbed capacity to take, digest, absorb, metabolise or excrete ordinary food or certain nutrients contained therein, or metabolites, or with other medically-determined nutrient requirements, whose dietary management cannot be achieved by modification of the normal diet alone;
‘total diet replacement for weight control’ means food specially formulated for use in energy restricted diets for weight reduction which, when used as instructed by the food business operator, replaces the whole daily diet.
Article 3
Interpretation decisions
In order to ensure the uniform implementation of this Regulation, the Commission may decide, by means of implementing acts:
whether a given food falls within the scope of this Regulation;
to which specific category of food referred to in Article 1(1) a given food belongs.
Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 17(2).
Article 4
Placing on the market
Article 5
Precautionary principle
In order to ensure a high level of health protection in relation to the persons for whom the food referred to in Article 1(1) of this Regulation is intended, the precautionary principle as set out in Article 7 of Regulation (EC) No 178/2002 shall apply.
CHAPTER II
COMPOSITIONAL AND INFORMATION REQUIREMENTS
SECTION 1
General requirements
Article 6
General provisions
Article 7
Opinions of the Authority
The Authority shall provide scientific opinions in accordance with Articles 22 and 23 of Regulation (EC) No 178/2002 for the purpose of the application of this Regulation. Those opinions shall serve as the scientific basis for any Union measure adopted pursuant to this Regulation which is likely to have an effect on public health.
Article 8
Access to documents
The Commission shall apply Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents ( 1 ) to applications for access to any document covered by this Regulation.
Article 9
General compositional and information requirements
For substances which are engineered nanomaterials, compliance with the requirement referred to in the first subparagraph shall be demonstrated on the basis of adequate test methods, where appropriate.
Article 10
Additional requirements for infant formula and follow-on formula
Without prejudice to the first subparagraph, graphic representations for easy identification of infant formula and follow-on formula and for illustrating methods of preparation shall be permitted.
SECTION 2
Specific requirements
Article 11
Specific compositional and information requirements
Subject to the general requirements set out in Articles 6 and 9, to the additional requirements of Article 10, and taking into account relevant technical and scientific progress, the Commission shall be empowered to adopt delegated acts in accordance with Article 18, with respect to the following:
the specific compositional requirements applicable to food referred to in Article 1(1), with the exception of requirements as set out in the Annex;
the specific requirements on the use of pesticides in products intended for the production of food referred to in Article 1(1) and on pesticide residues in such food. The specific requirements for the categories of food referred to in points (a) and (b) of Article 1(1) and food for special medical purposes developed to satisfy the nutritional requirements of infants and young children shall be updated regularly and include, inter alia, provisions to restrict the use of pesticides as much as possible;
the specific requirements on labelling, presentation and advertising of food referred to in Article 1(1), including the authorisation of nutrition and health claims in relation thereto;
the notification requirements for the placing on the market of food referred to in Article 1(1), in order to facilitate the efficient official monitoring of such food, and on the basis of which food business operators shall notify the competent authorities of Member States where that food is being marketed;
the requirements concerning promotional and commercial practices relating to infant formula;
the requirements concerning information to be provided in relation to infant and young child feeding in order to ensure adequate information on appropriate feeding practices;
the specific requirements for food for special medical purposes developed to satisfy the nutritional requirements of infants, including compositional requirements and requirements on the use of pesticides in products intended for the production of such food, pesticide residues, labelling, presentation, advertising, and promotional and commercial practices, as appropriate.
These delegated acts shall be adopted by 20 July 2015.
Where in the case of emerging health risks, imperative grounds of urgency so require, the procedure provided for in Article 19 shall apply to delegated acts adopted pursuant to this paragraph.
Article 12
Milk-based drinks and similar products intended for young children
By 20 July 2015, the Commission shall, after consulting the Authority, present to the European Parliament and to the Council a report on the necessity, if any, of special provisions for milk-based drinks and similar products intended for young children regarding compositional and labelling requirements and, if appropriate, other types of requirements. The Commission shall consider in the report, inter alia, the nutritional requirements of young children, the role of those products in the diet of young children and whether those products have any nutritional benefits when compared to a normal diet for a child who is being weaned. Such a report may, if necessary, be accompanied by an appropriate legislative proposal.
Article 13
Food intended for sportspeople
By 20 July 2015, the Commission shall, after consulting the Authority, present to the European Parliament and to the Council a report on the necessity, if any, of provisions for food intended for sportspeople. Such a report may, if necessary, be accompanied by an appropriate legislative proposal.
Article 14
Technical guidelines
The Commission may adopt technical guidelines to facilitate compliance by food business operators, in particular SMEs, with this Chapter and Chapter III.
CHAPTER III
UNION LIST
Article 15
Union list
Substances belonging to the following categories of substances may be added to one or more of the categories of food referred to in Article 1(1), provided that these substances are included in the Union list set out in the Annex and comply with the elements contained in the Union list in accordance with paragraph 3 of this Article:
vitamins;
minerals;
amino acids;
carnitine and taurine;
nucleotides;
choline and inositol.
The Union list shall contain the following elements:
the category of food referred to in Article 1(1) to which substances belonging to the categories of substances listed in paragraph 1 of this Article may be added;
the name, the description of the substance and, where appropriate, the specification of its form;
where appropriate, the conditions of use of the substance;
where appropriate, the purity criteria applicable to the substance.
Member States may maintain national rules setting stricter purity criteria.
In order to take into account technical progress, scientific developments or the protection of consumers’ health, the Commission shall be empowered to adopt, in relation to the categories of substances listed in paragraph 1 of this Article, delegated acts in accordance with Article 18 with respect to the following:
the removal of a category of substances;
the addition of a category of substances that have a nutritional or physiological effect.
Article 16
Updating the Union list
Subject to the general requirements set out in Articles 6 and 9 and, where applicable, the specific requirements established in accordance with Article 11, and in order to take into account technical progress, scientific developments or the protection of consumers’ health, the Commission shall be empowered to adopt delegated acts in accordance with Article 18, to amend the Annex, with respect to the following:
the addition of a substance to the Union list;
the removal of a substance from the Union list;
the addition, removal or amendment of the elements referred to in Article 15(3).
CHAPTER IV
PROCEDURAL PROVISIONS
Article 17
Committee procedure
Where the opinion of the committee is to be obtained by written procedure, that procedure shall be terminated without result when, within the time-limit for delivery of the opinion, the chair of the committee so decides or a simple majority of committee members so request.
Article 18
Exercise of the delegation
Article 19
Urgency procedure
CHAPTER V
FINAL PROVISIONS
Article 20
Repeal
In the case of conflict between Regulation (EC) No 953/2009, Directives 96/8/EC, 1999/21/EC, 2006/125/EC, 2006/141/EC and this Regulation, this Regulation shall prevail.
Article 21
Transitional measures
Where the date of application of the delegated acts referred to in Article 11(1) of this Regulation is after 20 July 2016, food referred to in Article 1(1) which complies with this Regulation and, as applicable, with Regulation (EC) No 953/2009 and Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC but does not comply with those delegated acts, and which is placed on the market or labelled before the date of application of those delegated acts, may continue to be marketed after that date until stocks of such food are exhausted.
Article 22
Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 20 July 2016, with the exception of the following:
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX
Union list as referred to in Article 15(1)
Substance |
Category of food |
|||||
Infant formula and follow on formula |
Processed cereal-based food and baby food |
Food for special medical purposes |
Total diet replacement for weight control |
|||
Vitamins |
|
|
|
|
|
|
Vitamin A |
|
|
|
|
|
|
retinol |
X |
X |
X |
X |
||
retinyl acetate |
X |
X |
X |
X |
||
retinyl palmitate |
X |
X |
X |
X |
||
beta-carotene |
|
X |
X |
X |
||
Vitamin D |
|
|
|
|
|
|
ergocalciferol |
X |
X |
X |
X |
||
cholecalciferol |
X |
X |
X |
X |
||
Vitamin E |
|
|
|
|
|
|
D-alpha tocopherol |
X |
X |
X |
X |
||
DL-alpha tocopherol |
X |
X |
X |
X |
||
D-alpha tocopheryl acetate |
X |
X |
X |
X |
||
DL-alpha tocopheryl acetate |
X |
X |
X |
X |
||
D-alpha-tocopheryl acid succinate |
|
|
X |
X |
||
D-alpha-tocopheryl polyethylene glycol-1000 succinate (TPGS) |
|
|
X |
|
||
Vitamin K |
|
|
|
|
|
|
phylloquinone (phytomenadione) |
X |
X |
X |
X |
||
Menaquinone (1) |
|
|
X |
X |
||
Vitamin C |
|
|
|
|
|
|
L-ascorbic acid |
X |
X |
X |
X |
||
sodium-L-ascorbate |
X |
X |
X |
X |
||
calcium-L-ascorbate |
X |
X |
X |
X |
||
potassium-L-ascorbate |
X |
X |
X |
X |
||
L-ascorbyl 6-palmitate |
X |
X |
X |
X |
||
Thiamin |
|
|
|
|
|
|
thiamin hydrochloride |
X |
X |
X |
X |
||
thiamin mononitrate |
X |
X |
X |
X |
||
Riboflavin |
|
|
|
|
|
|
riboflavin |
X |
X |
X |
X |
||
riboflavin 5’-phosphate, sodium |
X |
X |
X |
X |
||
Niacin |
|
|
|
|
|
|
nicotinic acid |
X |
X |
X |
X |
||
nicotinamide |
X |
X |
X |
X |
||
nicotinamide riboside chloride |
|
|
X |
X |
||
Vitamin B6 |
|
|
|
|
|
|
pyridoxine hydrochloride |
X |
X |
X |
X |
||
pyridoxine 5’-phosphate |
X |
X |
X |
X |
||
pyridoxine dipalmitate |
|
X |
X |
X |
||
Folate |
|
|
|
|
|
|
folic acid (pteroylmonoglutamic acid) |
X |
X |
X |
X |
||
calcium-L-methylfolate |
X |
X |
X |
X |
||
Vitamin B12 |
|
|
|
|
|
|
cyanocobalamin |
X |
X |
X |
X |
||
hydroxocobalamin |
X |
X |
X |
X |
||
Biotin |
|
|
|
|
|
|
D-biotin |
X |
X |
X |
X |
||
Pantothenic Acid |
|
|
|
|
|
|
D-pantothenate, calcium |
X |
X |
X |
X |
||
D-pantothenate, sodium |
X |
X |
X |
X |
||
dexpanthenol |
X |
X |
X |
X |
||
Minerals |
|
|
|
|
|
|
Potassium |
|
|
|
|
|
|
potassium bicarbonate |
X |
|
X |
X |
||
potassium carbonate |
X |
|
X |
X |
||
potassium chloride |
X |
X |
X |
X |
||
potassium citrate |
X |
X |
X |
X |
||
potassium gluconate |
X |
X |
X |
X |
||
potassium glycerophosphate |
|
X |
X |
X |
||
potassium lactate |
X |
X |
X |
X |
||
potassium hydroxide |
X |
|
X |
X |
||
potassium salts of orthophosphoric acid |
X |
|
X |
X |
||
magnesium potassium citrate |
|
|
X |
X |
||
Calcium |
|
|
|
|
|
|
calcium carbonate |
X |
X |
X |
X |
||
calcium chloride |
X |
X |
X |
X |
||
calcium salts of citric acid |
X |
X |
X |
X |
||
calcium gluconate |
X |
X |
X |
X |
||
calcium glycerophosphate |
X |
X |
X |
X |
||
calcium lactate |
X |
X |
X |
X |
||
calcium salts of orthophosphoric acid |
X |
X |
X |
X |
||
calcium hydroxide |
X |
X |
X |
X |
||
calcium oxide |
|
X |
X |
X |
||
calcium sulphate |
|
|
X |
X |
||
calcium bisglycinate |
|
|
X |
X |
||
calcium citrate malate |
|
|
X |
X |
||
calcium malate |
|
|
X |
X |
||
calcium L-pidolate |
|
|
X |
X |
||
calcium phosphoryl oligosaccharides |
|
|
X |
|
||
Magnesium |
|
|
|
|
|
|
magnesium acetate |
|
|
X |
X |
||
magnesium carbonate |
X |
X |
X |
X |
||
magnesium chloride |
X |
X |
X |
X |
||
magnesium salts of citric acid |
X |
X |
X |
X |
||
magnesium gluconate |
X |
X |
X |
X |
||
magnesium glycerophosphate |
|
X |
X |
X |
||
magnesium salts of orthophosphoric acid |
X |
X |
X |
X |
||
magnesium lactate |
|
X |
X |
X |
||
magnesium hydroxide |
X |
X |
X |
X |
||
magnesium oxide |
X |
X |
X |
X |
||
magnesium sulphate |
X |
X |
X |
X |
||
magnesium L-aspartate |
|
|
X |
|
||
magnesium bisglycinate |
|
|
X |
X |
||
magnesium L-pidolate |
|
|
X |
X |
||
magnesium potassium citrate |
|
|
X |
X |
||
Iron |
|
|
|
|
|
|
ferrous carbonate |
|
X |
X |
X |
||
ferrous citrate |
X |
X |
X |
X |
||
ferric ammonium citrate |
X |
X |
X |
X |
||
ferrous gluconate |
X |
X |
X |
X |
||
ferrous fumarate |
X |
X |
X |
X |
||
ferric sodium diphosphate |
|
X |
X |
X |
||
ferrous lactate |
X |
X |
X |
X |
||
ferrous sulphate |
X |
X |
X |
X |
||
ferrous ammonium phosphate |
|
|
X |
X |
||
ferric sodium EDTA |
|
|
X |
X |
||
ferric diphosphate (ferric pyrophosphate) |
X |
X |
X |
X |
||
ferric saccharate |
|
X |
X |
X |
||
elemental iron (carbonyl + electrolytic + hydrogen reduced) |
|
X |
X |
X |
||
ferrous bisglycinate |
X |
X |
X |
X |
||
ferrous L-pidolate |
|
|
X |
X |
||
Zinc |
|
|
|
|
|
|
zinc acetate |
X |
X |
X |
X |
||
zinc chloride |
X |
X |
X |
X |
||
zinc citrate |
X |
X |
X |
X |
||
zinc gluconate |
X |
X |
X |
X |
||
zinc lactate |
X |
X |
X |
X |
||
zinc oxide |
X |
X |
X |
X |
||
zinc carbonate |
|
|
X |
X |
||
zinc sulphate |
X |
X |
X |
X |
||
zinc bisglycinate |
|
|
X |
X |
||
Copper |
|
|
|
|
|
|
cupric carbonate |
X |
X |
X |
X |
||
cupric citrate |
X |
X |
X |
X |
||
cupric gluconate |
X |
X |
X |
X |
||
cupric sulphate |
X |
X |
X |
X |
||
copper lysine complex |
X |
X |
X |
X |
||
Manganese |
|
|
|
|
|
|
manganese carbonate |
X |
X |
X |
X |
||
manganese chloride |
X |
X |
X |
X |
||
manganese citrate |
X |
X |
X |
X |
||
manganese gluconate |
X |
X |
X |
X |
||
manganese glycerophosphate |
|
X |
X |
X |
||
manganese sulphate |
X |
X |
X |
X |
||
Fluoride |
|
|
|
|
|
|
potassium fluoride |
|
|
X |
X |
||
sodium fluoride |
|
|
X |
X |
||
Selenium |
|
|
|
|
|
|
sodium selenate |
X |
|
X |
X |
||
sodium hydrogen selenite |
|
|
X |
X |
||
sodium selenite |
X |
|
X |
X |
||
selenium enriched yeast (2) |
|
|
X |
X |
||
Chromium |
|
|
|
|
|
|
chromium (III) chloride and its hexahydrate |
|
|
X |
X |
||
chromium (III) sulphate and its hexahydrate |
|
|
X |
X |
||
chromium picolinate |
|
|
X |
X |
||
Molybdenum |
|
|
|
|
|
|
ammonium molybdate |
|
|
X |
X |
||
sodium molybdate |
|
|
X |
X |
||
Iodine |
|
|
|
|
|
|
potassium iodide |
X |
X |
X |
X |
||
potassium iodate |
X |
X |
X |
X |
||
sodium iodide |
X |
X |
X |
X |
||
sodium iodate |
|
X |
X |
X |
||
Sodium |
|
|
|
|
|
|
sodium bicarbonate |
X |
|
X |
X |
||
sodium carbonate |
X |
|
X |
X |
||
sodium chloride |
X |
|
X |
X |
||
sodium citrate |
X |
|
X |
X |
||
sodium gluconate |
X |
|
X |
X |
||
sodium lactate |
X |
|
X |
X |
||
sodium hydroxide |
X |
|
X |
X |
||
sodium salts of orthophosphoric acid |
X |
|
X |
X |
||
Boron |
|
|
|
|
|
|
sodium borate |
|
|
X |
X |
||
boric acid |
|
|
X |
X |
||
Amino acids (3) |
|
|
|
|
|
|
L-alanine |
|
— |
X |
X |
||
L-arginine |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
L-aspartic acid |
|
|
X |
|
||
L-citrulline |
|
|
X |
|
||
L-cysteine |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
Cystine (4) |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
L-histidine |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
L-glutamic acid |
|
|
X |
X |
||
L-glutamine |
|
|
X |
X |
||
glycine |
|
|
X |
|
||
L-isoleucine |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
L-leucine |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
L-lysine |
X and its hydrochloride |
X and its hydrochloride |
X |
X |
||
L-lysine acetate |
|
|
X |
X |
||
L-methionine |
X |
X |
X |
X |
||
L-ornithine |
|
|
X |
X |
||
L-phenylalanine |
X |
X |
X |
X |
||
L-proline |
|
|
X |
|
||
L-threonine |
X |
X |
X |
X |
||
L-tryptophan |
X |
X |
X |
X |
||
L-tyrosine |
X |
X |
X |
X |
||
L-valine |
X |
X |
X |
X |
||
L-serine |
|
|
X |
|
||
L-arginine-L-aspartate |
|
|
X |
|
||
L-lysine-L-aspartate |
|
|
X |
|
||
L-lysine-L-glutamate |
|
|
X |
|
||
N-acetyl-L-cysteine |
|
|
X |
|
||
N-acetyl-L-methionine |
|
|
X (in products intended for persons over 1 year of age) |
|
||
Carnitine and taurine |
|
|
|
|
|
|
L-carnitine |
X |
X |
X |
X |
||
L-carnitine hydrochloride |
X |
X |
X |
X |
||
taurine |
X |
|
X |
X |
||
L-carnitine-L-tartrate |
X |
|
X |
X |
||
Nucleotides |
|
|
|
|
|
|
adenosine 5’-phosphoric acid (AMP) |
X |
|
X |
X |
||
sodium salts of AMP |
X |
|
X |
X |
||
cytidine 5’-monophosphoric acid (CMP) |
X |
|
X |
X |
||
sodium salts of CMP |
X |
|
X |
X |
||
guanosine 5’-phosphoric acid (GMP) |
X |
|
X |
X |
||
sodium salts of GMP |
X |
|
X |
X |
||
inosine 5’-phosphoric acid (IMP) |
X |
|
X |
X |
||
sodium salts of IMP |
X |
|
X |
X |
||
uridine 5’-phosphoric acid (UMP) |
X |
|
X |
X |
||
sodium salts of UMP |
X |
|
X |
X |
||
Choline and inositol |
|
|
|
|
|
|
choline |
X |
X |
X |
X |
||
choline chloride |
X |
X |
X |
X |
||
choline bitartrate |
X |
X |
X |
X |
||
choline citrate |
X |
X |
X |
X |
||
inositol |
X |
X |
X |
X |
||
(1)
Menaquinone occurring principally as menaquinone-7 and, to a minor extent, menaquinone-6.
(2)
Selenium-enriched yeasts produced by culture in the presence of sodium selenite as selenium source and containing, in the dried form as marketed, not more than 2,5 mg Se/g. The predominant organic selenium species present in the yeast is selenomethionine (between 60 and 85 % of total extracted selenium in the product). The content of other organic selenium compounds including selenocysteine must not exceed 10 % of total extracted selenium. Levels of inorganic selenium normally must not exceed 1 % of total extracted selenium.
(3)
For amino acids used in infant formula, follow-on formula, processed cereal-based food and baby food only the hydrochloride specifically mentioned may be used. For amino acids used in food for special medical purposes and in total diet replacement for weight control, as far as applicable, also the sodium, potassium, calcium and magnesium salts as well as their hydrochlorides may be used.
(4)
In the case of use in infant formula, follow-on formula, processed cereal-based food and baby food, only the form L-cystine may be used. |
( 1 ) OJ L 145, 31.5.2001, p. 43.